Clinical recruitment (Research Unit: Sun Yat-sen University Cancer Center)
Dear Patients:
Greetings! Professor Xu Ruihua/Professor Zhao Hongyun of our hospital's Department of Internal Medicine are currently conducting a clinical trial on solid tumors. This study has been approved by our hospital's ethics committee.
√ Project Name: A Phase I clinical study to evaluate the safety, tolerability, biodistribution, biological effects, and preliminary efficacy of recombinant oncolytic virus M1 (VRT106) injection in treating locally advanced/metastatic solid tumors
√ Research Objective: To evaluate the safety, tolerability, pharmacokinetic characteristics, immunogenicity, and antitumor effects of intratumoral injection of VRT106 for treating locally advanced or metastatic solid tumors
If you meet the following inclusion/exclusion criteria, you may be eligible for this study:
Recruitment Criteria (Inclusion Criteria)
· Subjects fully understand the purpose, benefits, and risks of this study and voluntarily participate in the research.
· Patients with histologically or cytologically confirmed unresectable locally advanced or metastatic solid tumors that have failed systemic standard treatment or for which there is currently no effective standard treatment, such as hepatocellular carcinoma, cervical cancer, prostate cancer, and melanoma, etc.
· At least one lesion that is unresectable and accessible for direct intratumoral injection or intratumoral injection guided by imaging (lesion longest diameter (LD) 1-5cm, including boundary values)
· Age 18-75 years (inclusive)
· ECOG performance status score 0-1
· Adequate organ function
· The patient and their partner must use effective contraception throughout the treatment period and for at least 90 days after the last dose.
The above are the main inclusion/exclusion criteria. The final decision on whether a patient can be included in the study will be made by the study doctor according to the protocol. For more information about this study, please contact the doctor in charge of the study at our hospital:
Contact Person | Contact Information and Location |
Study Doctor: Danyan Ruan | Yuexiu Campus Outpatient Clinic: Room 221 on Wednesday afternoon, Room 223 on Friday morning |
Study Nurse: Wu Hua | Phone Number: 18127912755 Address: 3rd Floor, Building 2, Sun Yat-sen University Cancer Center, Yuexiu Campus |
Focus on us
Contact Information
Monday to Friday 9:00~17:00
Rooms 801-808 and 901-908, Building H, No. 3 Jiu Quan Road, Huangpu District, Guangzhou City
Copyright©2024 Virotech Pharmaceutical Technology Co., Ltd.
